New bladder cancer treatment available before full approval
NCT ID NCT06877676
Summary
This program provides early access to TAR-200 for people with high-risk bladder cancer that hasn't spread into the muscle wall. It's for patients who have tried other treatments like BCG therapy but still have cancer, and who cannot or choose not to have their bladder surgically removed. The treatment involves placing a device in the bladder to deliver medication directly to the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-MUSCLE INVASIVE BLADDER NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.